{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:02:21Z","timestamp":1791910941272,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s43440-020-00074-6","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T12:02:32Z","timestamp":1583150552000},"page":"296-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessment of vitamin D and inflammatory markers profile in cardiac tissue on Parkinson disease animal model"],"prefix":"10.1007","volume":"72","author":[{"given":"Mariana Bocca","family":"Nejm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia Jonathas","family":"Guimar\u00e3es-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Freitas","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrain","family":"Olszewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Le\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlo G.","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio Alexandre","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Alessandra","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"74_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-017-0017-1","volume":"3","author":"P Borghammer","year":"2017","unstructured":"Borghammer P, Knudsen K, Fedorova TD, Brooks DJ. Imaging Parkinson\u2019s disease below the neck. NPJ Park Dis. 2017;3:15. https:\/\/doi.org\/10.1038\/s41531-017-0017-1.","journal-title":"NPJ Park Dis"},{"key":"74_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00702-017-1692-0","volume":"124","author":"L Klingelhoefer","year":"2017","unstructured":"Klingelhoefer L, Reichmann H. Parkinson\u2019s disease as a multisystem disorder. J Neural Transm. 2017;124:709\u201313. https:\/\/doi.org\/10.1007\/s00702-017-1692-0.","journal-title":"J Neural Transm"},{"key":"74_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10286-018-00584-7","volume":"29","author":"JM Metzger","year":"2019","unstructured":"Metzger JM, Emborg ME. Autonomic dysfunction in Parkinson disease and animal models. Clin Auton Res. 2019;29:397\u2013414. https:\/\/doi.org\/10.1007\/s10286-018-00584-7.","journal-title":"Clin Auton Res"},{"key":"74_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.6061\/clinics\/2017(11)01","volume":"72","author":"F Scorza","year":"2017","unstructured":"Scorza F, Carmo A, Fiorini A, Nejm M, Scorza C, Finsterer J, et al. Sudden unexpected death in Parkinson\u2019s disease (SUDPAR): a review of publications since the decade of the brain. Clinics. 2017;72:649\u201351. https:\/\/doi.org\/10.6061\/clinics\/2017(11)01.","journal-title":"Clinics"},{"key":"74_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/mds.26060","volume":"30","author":"B Pinter","year":"2015","unstructured":"Pinter B, Diem-Zangerl A, Wenning GK, Scherfler C, Oberaigner W, Seppi K, et al. Mortality in Parkinson\u2019s disease: a 38-year follow-up study. Mov Disord. 2015;30:266\u20139. https:\/\/doi.org\/10.1002\/mds.26060.","journal-title":"Mov Disord"},{"key":"74_CR6","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jnr.21642","volume":"86","author":"I Branchi","year":"2008","unstructured":"Branchi I, D\u2019Andrea I, Armida M, Cassano T, P\u00e8zzola A, Potenza RL, et al. Nonmotor symptoms in Parkinson\u2019s disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model. J Neurosci Res. 2008;86:2050\u201361. https:\/\/doi.org\/10.1002\/jnr.21642.","journal-title":"J Neurosci Res"},{"key":"74_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","volume":"156","author":"MT Tadaiesky","year":"2008","unstructured":"Tadaiesky MT, Dombrowski PA, Figueiredo CP, Cargnin-Ferreira E, Da Cunha C, Takahashi RN. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s disease. Neuroscience. 2008;156:830\u201340. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.035.","journal-title":"Neuroscience"},{"key":"74_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0079-6123(10)84002-6","volume":"184","author":"JR Cannon","year":"2010","unstructured":"Cannon JR, Greenamyre JT. Neurotoxic in vivo models of Parkinson\u2019s disease. Prog Brain Res. 2010;184:17\u201333. https:\/\/doi.org\/10.1016\/S0079-6123(10)84002-6.","journal-title":"Prog Brain Res"},{"key":"74_CR9","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/427810","author":"JM Henderson","year":"2010","unstructured":"Henderson JM, Slack K, Billing R, Matthews S, Allbutt HN, Einstein R. Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat. Parkinsons Dis. 2010. https:\/\/doi.org\/10.4061\/2010\/427810.","journal-title":"Parkinsons Dis"},{"key":"74_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45518-z","author":"LD Rodrigues","year":"2019","unstructured":"Rodrigues LD, Oliveira LF, Shinoda L, Scorza CA, Faber J, Ferraz HB, et al. Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-45518-z.","journal-title":"Sci Rep"},{"key":"74_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: Mechanisms and models. Neuron. 2003;39:889\u2013909. https:\/\/doi.org\/10.1016\/S0896-6273(03)00568-3.","journal-title":"Neuron"},{"key":"74_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","volume":"2","author":"J Bov\u00e9","year":"2005","unstructured":"Bov\u00e9 J, Prou D, Perier C, Przedborski S. Toxin-induced models of Parkinson\u2019s disease. NeuroRx. 2005;2:484\u201394. https:\/\/doi.org\/10.1602\/neurorx.2.3.484.","journal-title":"NeuroRx"},{"key":"74_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2013.01.060","volume":"237","author":"CC Real","year":"2013","unstructured":"Real CC, Ferreira AFB, Chaves-Kirsten GP, Torr\u00e3o AS, Pires RS, Britto LRG. BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson\u2019s disease. Neuroscience. 2013;237:118\u201329. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.01.060.","journal-title":"Neuroscience"},{"key":"74_CR14","doi-asserted-by":"publisher","first-page":"427810","DOI":"10.4061\/2010\/427810","volume":"2010","author":"K Slack","year":"2010","unstructured":"Slack K, Billing R, Matthews S, Allbutt HN, Einstein R, Henderson JM. Subtle cardiovascular dysfunction in the unilateral 6-hydroxydopamine-lesioned rat. Parkinsons Dis. 2010;2010:427810. https:\/\/doi.org\/10.4061\/2010\/427810.","journal-title":"Parkinsons Dis"},{"key":"74_CR15","doi-asserted-by":"publisher","first-page":"H250","DOI":"10.1152\/ajpheart.00406.2014","volume":"308","author":"D Ariza","year":"2015","unstructured":"Ariza D, Sisdeli L, Crestani CC, Fazan R, Martins-Pinge MC. Dysautonomias in parkinson\u2019s disease: Cardiovascular changes and autonomic modulation in conscious rats after infusion of bilateral 6-OHDA in substantia nigra. Am J Physiol Hear Circ Physiol. 2015;308:H250\u2013H257257. https:\/\/doi.org\/10.1152\/ajpheart.00406.2014.","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"74_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2016.12.008","volume":"1657","author":"B Falquetto","year":"2017","unstructured":"Falquetto B, Tuppy M, Potje SR, Moreira TS, Antoniali C, Takakura AC. Cardiovascular dysfunction associated with neurodegeneration in an experimental model of Parkinson\u2019s disease. Brain Res. 2017;1657:156\u201366. https:\/\/doi.org\/10.1016\/j.brainres.2016.12.008.","journal-title":"Brain Res"},{"key":"74_CR17","first-page":"175","volume":"74","author":"L Angy\u00e1n","year":"1989","unstructured":"Angy\u00e1n L. Role of the substantia nigra in the behavioural-cardiovascular integration in the cat. Acta Physiol Hung. 1989;74:175\u201387.","journal-title":"Acta Physiol Hung"},{"key":"74_CR18","doi-asserted-by":"publisher","first-page":"H2489","DOI":"10.1152\/ajpheart.1994.266.6.H2489","volume":"266","author":"MT Lin","year":"1994","unstructured":"Lin MT, Yang JJ. Stimulation of the nigrostriatal dopamine system produces hypertension and tachycardia in rats. Am J Physiol. 1994;266:H2489\u2013H24962496. https:\/\/doi.org\/10.1152\/ajpheart.1994.266.6.H2489.","journal-title":"Am J Physiol"},{"key":"74_CR19","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/sj.bjp.0704401","volume":"134","author":"A Lessard","year":"2001","unstructured":"Lessard A, Couture R. Modulation of cardiac activity by tachykinins in the rat substantia nigra. Br J Pharmacol. 2001;134:1749\u201359. https:\/\/doi.org\/10.1038\/sj.bjp.0704401.","journal-title":"Br J Pharmacol"},{"key":"74_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1113\/jphysiol.2001.014621","volume":"539","author":"JM Thornton","year":"2002","unstructured":"Thornton JM, Aziz T, Schlugman D, Paterson DJ. Electrical stimulation of the midbrain increases heart rate and arterial blood pressure in awake humans. J Physiol. 2002;539:615\u201321. https:\/\/doi.org\/10.1113\/jphysiol.2001.014621.","journal-title":"J Physiol"},{"key":"74_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.amjhyper.2006.03.005","volume":"19","author":"TL Yeh","year":"2006","unstructured":"Yeh TL, Yang YK, Chiu NT, Yao WJ, Yeh SJ, Wu JS, et al. Correlation between striatal dopamine D 2 \/D 3 receptor binding and cardiovascular activity in healthy subjects. Am J Hypertens. 2006;19:964\u20139. https:\/\/doi.org\/10.1016\/j.amjhyper.2006.03.005.","journal-title":"Am J Hypertens"},{"key":"74_CR22","first-page":"H2549","volume":"273","author":"GJ Kirouac","year":"1997","unstructured":"Kirouac GJ, Ciriello J. Cardiovascular depressor responses to stimulation of substantia nigra and ventral tegmental area. Am J Physiol. 1997;273:H2549\u2013H25572557.","journal-title":"Am J Physiol"},{"key":"74_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/cne.1098","volume":"432","author":"A Roedter","year":"2001","unstructured":"Roedter A, Winkler C, Samii M, Walter GF, Brandis A, Nikkhah G. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: Evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J Comp Neurol. 2001;432:217\u201329. https:\/\/doi.org\/10.1002\/cne.1098.","journal-title":"J Comp Neurol"},{"key":"74_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2011.00092","author":"J Blesa","year":"2011","unstructured":"Blesa J, Juri C, Garcia-Cabezas M\u00c1, Ad\u00e1nez R, S\u00e1nchez-Gonz\u00e1lez M\u00c1, Cavada C, et al. Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson\u2019s disease. Front Syst Neurosci. 2011. https:\/\/doi.org\/10.3389\/fnsys.2011.00092.","journal-title":"Front Syst Neurosci"},{"key":"74_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.expneurol.2013.04.013","volume":"247","author":"B Pollok","year":"2013","unstructured":"Pollok B, Kamp D, Butz M, Wojtecki L, Timmermann L, S\u00fcdmeyer M, et al. Increased SMA-M1 coherence in Parkinson\u2019s disease\u2014pathophysiology or compensation? Exp Neurol. 2013;247:178\u201381. https:\/\/doi.org\/10.1016\/j.expneurol.2013.04.013.","journal-title":"Exp Neurol"},{"key":"74_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010;67:715\u201325. https:\/\/doi.org\/10.1002\/ana.21995.","journal-title":"Ann Neurol"},{"key":"74_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/archneur.63.4.584","volume":"63","author":"S Greffard","year":"2006","unstructured":"Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, et al. Motor score of the unified Parkinson disease rating scale as a good predictor of lewy body-associated neuronal loss in the substantia nigra. Arch Neurol. 2006;63:584\u20138. https:\/\/doi.org\/10.1001\/archneur.63.4.584.","journal-title":"Arch Neurol"},{"key":"74_CR28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/ana.24393","volume":"77","author":"A Alonso","year":"2015","unstructured":"Alonso A, Huang X, Mosley TH, Heiss G, Chen H. Heart rate variability and the risk of Parkinson disease: the Atherosclerosis Risk in Communities study. Ann Neurol. 2015;77:877\u201383. https:\/\/doi.org\/10.1002\/ana.24393.","journal-title":"Ann Neurol"},{"key":"74_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112482","author":"C Di Somma","year":"2017","unstructured":"Di Somma C, Scarano E, Barrea L, Zhukouskaya VV, Savastano S, Mele C, et al. Vitamin D and neurological diseases: an endocrine view. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18112482.","journal-title":"Int J Mol Sci"},{"key":"74_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S2213-8587(13)70165-7","volume":"2","author":"P Autier","year":"2014","unstructured":"Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2:76\u201389. https:\/\/doi.org\/10.1016\/S2213-8587(13)70165-7.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"74_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40885-018-0094-4","volume":"24","author":"B Kheiri","year":"2018","unstructured":"Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens. 2018;24:9. https:\/\/doi.org\/10.1186\/s40885-018-0094-4.","journal-title":"Clin Hypertens"},{"key":"74_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1677\/JOE-08-0241","volume":"200","author":"JN Artaza","year":"2009","unstructured":"Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol. 2009;200:207\u201321. https:\/\/doi.org\/10.1677\/JOE-08-0241.","journal-title":"J Endocrinol"},{"key":"74_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.110.160929","volume":"57","author":"KL Jablonski","year":"2011","unstructured":"Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertens (Dallas, Tex 1979). 2011;57:63\u20139. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.160929.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"74_CR34","doi-asserted-by":"publisher","first-page":"038","DOI":"10.1097\/CRD.0b013e31822c5380","volume":"20","author":"Y Liss","year":"2012","unstructured":"Liss Y, Frishman WH. Vitamin D. Cardiol Rev. 2012;20:038\u201344. https:\/\/doi.org\/10.1097\/CRD.0b013e31822c5380.","journal-title":"Cardiol Rev"},{"key":"74_CR35","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1172\/JCI67804","volume":"123","author":"I Ito","year":"2013","unstructured":"Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, et al. A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest. 2013;123:4579\u201394. https:\/\/doi.org\/10.1172\/JCI67804.","journal-title":"J Clin Invest"},{"key":"74_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0006-8993(01)02450-7","volume":"904","author":"JY Wang","year":"2001","unstructured":"Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001;904:67\u201375. https:\/\/doi.org\/10.1016\/s0006-8993(01)02450-7.","journal-title":"Brain Res"},{"key":"74_CR37","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3892\/etm.2017.4246","volume":"13","author":"G Liu","year":"2017","unstructured":"Liu G, Ma C, Yang H, Zhang P-Y. Transforming growth factor \u03b2 and its role in heart disease. Exp Ther Med. 2017;13:2123\u20138. https:\/\/doi.org\/10.3892\/etm.2017.4246.","journal-title":"Exp Ther Med"},{"key":"74_CR38","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1158\/0008-5472.CAN-05-3796","volume":"66","author":"L Nonn","year":"2006","unstructured":"Nonn L, Peng L, Feldman D, Peehl DM. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res. 2006;66:4516\u201324. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3796.","journal-title":"Cancer Res"},{"key":"74_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","volume":"56","author":"GC Mel\u00e9ndez","year":"2010","unstructured":"Mel\u00e9ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension (Dallas, Tex 1979). 2010;56:225\u201331. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.148635.","journal-title":"Hypertension (Dallas, Tex 1979)"},{"key":"74_CR40","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.5114\/aoms.2016.58635","volume":"13","author":"K Ptaszynska-Kopczynska","year":"2017","unstructured":"Ptaszynska-Kopczynska K, Szpakowicz A, Marcinkiewicz-Siemion M, Lisowska A, Waszkiewicz E, Witkowski M, et al. Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy. Arch Med Sci. 2017;13:1069\u201377. https:\/\/doi.org\/10.5114\/aoms.2016.58635.","journal-title":"Arch Med Sci"},{"key":"74_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/heartasia-2013-010484","volume":"6","author":"M Liu","year":"2014","unstructured":"Liu M, Chen J, Huang D, Ke J, Wu W. A meta-analysis of proinflammatory cytokines in chronic heart failure. Heart Asia. 2014;6:130\u20136. https:\/\/doi.org\/10.1136\/heartasia-2013-010484.","journal-title":"Heart Asia"},{"key":"74_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1001\/jamacardio.2019.0179","volume":"4","author":"P Mani","year":"2019","unstructured":"Mani P, Puri R, Schwartz GG, Nissen SE, Shao M, Kastelein JJP, et al. Association of initial and serial C-reactive protein levels with adverse cardiovascular events and death after acute coronary syndrome. JAMA Cardiol. 2019;4:314. https:\/\/doi.org\/10.1001\/jamacardio.2019.0179.","journal-title":"JAMA Cardiol"},{"key":"74_CR43","doi-asserted-by":"publisher","first-page":"e0131740","DOI":"10.1371\/journal.pone.0131740","volume":"10","author":"MC Liefaard","year":"2015","unstructured":"Liefaard MC, Ligthart S, Vitezova A, Hofman A, Uitterlinden AG, Kiefte-de Jong JC, et al. Vitamin D and C-reactive protein: a mendelian randomization study. PLoS One. 2015;10:e0131740. https:\/\/doi.org\/10.1371\/journal.pone.0131740.","journal-title":"PLoS One"},{"key":"74_CR44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.clinbiochem.2016.01.002","volume":"49","author":"A Kruit","year":"2016","unstructured":"Kruit A, Zanen P. The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases. Clin Biochem. 2016;49:534\u20137. https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.01.002.","journal-title":"Clin Biochem"},{"key":"74_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00007","author":"SJP Haas","year":"2016","unstructured":"Haas SJP, Zhou X, Machado V, Wree A, Krieglstein K, Spittau B. Expression of tgf\u03b21 and inflammatory markers in the 6-hydroxydopamine mouse model of Parkinson\u2019s disease. Front Mol Neurosci. 2016. https:\/\/doi.org\/10.3389\/fnmol.2016.00007.","journal-title":"Front Mol Neurosci"},{"key":"74_CR46","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s11064-010-0133-3","volume":"35","author":"SJ Na","year":"2010","unstructured":"Na SJ, DiLella AG, Lis EV, Jones K, Levine DM, Stone DJ, et al. Molecular profiling of a 6-hydroxydopamine model of parkinson\u2019s disease. Neurochem Res. 2010;35:761\u201372. https:\/\/doi.org\/10.1007\/s11064-010-0133-3.","journal-title":"Neurochem Res"},{"key":"74_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuroscience.2010.12.005","volume":"175","author":"S Walsh","year":"2011","unstructured":"Walsh S, Finn DP, Dowd E. Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson\u2019s disease in the rat. Neuroscience. 2011;175:251\u201361. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.12.005.","journal-title":"Neuroscience"},{"key":"74_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070951","author":"D Hernandez-Baltazar","year":"2013","unstructured":"Hernandez-Baltazar D, Mendoza-Garrido ME, Martinez-Fong D. Activation of GSK-3\u03b2 and caspase-3 occurs in nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine. PLoS One. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0070951.","journal-title":"PLoS One"},{"key":"74_CR49","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/ejn.12459","volume":"39","author":"SRW Stott","year":"2014","unstructured":"Stott SRW, Barker RA. Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson\u2019s disease. Eur J Neurosci. 2014;39:1042\u201356. https:\/\/doi.org\/10.1111\/ejn.12459.","journal-title":"Eur J Neurosci"},{"key":"74_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12974-016-0608-5","volume":"13","author":"C Pellegrini","year":"2016","unstructured":"Pellegrini C, Fornai M, Colucci R, Tirotta E, Blandini F, Levandis G, et al. Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration. J Neuroinflammation. 2016;13:146. https:\/\/doi.org\/10.1186\/s12974-016-0608-5.","journal-title":"J Neuroinflammation"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00074-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43440-020-00074-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00074-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:27:48Z","timestamp":1614644868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43440-020-00074-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00074-6","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"26 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors has any conflict of interest to disclose. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}